Dofetilide dose calculation errors in elderly associated with use of the modification of diet in renal disease equation

Annals of Pharmacotherapy

Volumn 45, Issue 7-8, 2011, Pages

  Denetclaw, Tina H ^a   Oshima, Nancy ^b   Dowling, Thomas C ^c  

^a Marin General Hospital   (United States)

^b TOURO UNIVERSITY CALIFORNIA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Creatinine clearance; Dofetilide; MDRD equation; Renal dosing

Indexed keywords

CARVEDILOL; DOFETILIDE; DRONEDARONE; FUROSEMIDE; HYDRALAZINE; INSULIN LISPRO; ISOSORBIDE; SITAGLIPTIN; SOTALOL; WARFARIN;

AGED; ARTICLE; CARDIOVERSION; CASE REPORT; CONGESTIVE HEART FAILURE; CREATININE CLEARANCE; DIET SUPPLEMENTATION; DIZZINESS; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; GERIATRICS; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HUMAN; KIDNEY DISEASE; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; THERAPEUTIC ERROR;

EID: 79960772355     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q159     Document Type: Article

References (18)

1. Allen MJ, Nichols DJ, Oliver SD. The pharmacokinetics and pharmaco-dynamics of oral dofetilide after twice daily and three times daily dosing. Br J Clin Pharmacol 2000;50:247-53.
2. Product information. Tikosyn (dofetilide). New York, NY: November 2006.
3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
4. Jonker DM, Kenna LA, Leishman D, et al. A pharmacokinetic-pharma-codynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data. Clin Pharmacol Ther 2005;77:572-82.
5. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
6. Bailie GR, Uhlig K, Levey AS. Clinical practice guidelines in nephrolo-gy: evaluation, classification, and stratification of chronic kidney disease. Pharmacotherapy 2005;25:491-502.
7. Stevens LA, Nolin TD, Richardson MM, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009;54:33-42.
8. Golik MV, Lawrence KR. Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: Cockcroft-Gault and Modification of Diet in Renal Disease. Pharma-cotherapy 2008;28:1125-32.
9. Spruill WJ, Wade WE, Cobb HH 3rd. Continuing the use of the Cock-croft-Gault equation for drug dosing in patients with impaired renal function. Clin Pharmacol Ther 2009;86:468-70.
10. Gill J, Malyuk R, Djurdjev O, Levin A. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group-a cautionary tale. Nephrol Dial Transplant 2007;22:2894-99.
11. Melloni C, Peterson ED, Chen AY, et al. Cockcroft-Gault versus Modification of Diet in Renal Disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2008;51:991-6.
12. Roberts GW, Ibsen PM, Schioler CT. Modified Diet in Renal Disease method overestimates renal function in selected elderly patients. Age Ageing 2009;38:698-703.
13. Hermsen ED, Maiefski M, Florescu MC, et al. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials. Pharmacotherapy 2009;29:649-55.
14. Péquignot R, Belmin J, Chauvelier S, et al. Renal function in older hospital patients is more accurately estimated using the Cockcroft-Gault formula than the Modification of Diet in Renal Disease formula. J Am Geri-atr Soc 2009;57:1638-43.
15. Aktas MK, Shah AH, Akiyama T. Dofetilide-induced long QT and tor-sades de pointes. Ann Noninvasive Electrocardiol 2007;12:197-202.
16. Food and Drug Administration. Guidance for industry: pharmacokinetic studies in patients with impaired renal function-study design, data analysis, and impact on dosing and labeling. Rockville, MD: US Department of Health and Human Services, May 1998.
17. Dowling TC, Matzke GR, Murphy JE, Burckart GJ. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacotherapy 2010;30:776-786.
18. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.